After tackling Covid-19 with AstraZeneca, Oxford's Jenner Institute is hard at work on a different kind of vaccine
The institute behind AstraZeneca’s Covid-19 vaccine with Oxford University just got funding to pursue a different kind of vaccine for an infection that’s not quite as pressing, but nevertheless on the rise.
The Jenner Institute was awarded $2 million from CARB-X to create a vaccine candidate for gonorrhea, a bacterial infection that has developed resistance to most antibiotics. The money comes from CARB-X, a global partnership looking to spur the development of new antibacterial drugs. And there’s plenty more where that came from, the initiative announced early Tuesday morning.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
